Omeros (OMER) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.04B, a trailing price-to-earnings ratio of 4.7 and a free-cash-flow yield of -13.1%. Nama's AI scorecard rates it Sell, 4.0 out of 10. On 12-month momentum it ranks in the rising band of its market.
AI scorecard
Sell · 4.0/10
Negative, at the mild end of Sell. As of Nov 20, 2026.
Momentum
Rising · +97.6% over 12 months ex. last
Second-best fifth of its market on the past year's move.
Shariah screen
Can't Tell
A figure the screen needs is missing, so it can't tell.
Off its high
-37.8%
How far the last close sits under the highest price of the past five years.
Market cap
$1.04B
Trailing P/E
4.7
Price / book
—
Price / sales
26.4
FCF yield
-13.1%
Dividend yield
—
Gross margin
96.4%
Operating margin
-189.5%
Net margin
324.9%
Revenue growth (YoY)
—
Revenue growth (3-yr annual)
—
EPS growth (YoY)
—
FCF/share growth (YoY)
—
Beta
3.0
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
OMER earnings
Next report: Mar 31, 2027 (Q4 2026, EPS estimate $0.25).
Beat the EPS estimate in 3 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Nov 16, 2026
-$0.85
-$0.02
-4150.0%
$35.93M
Q2 2026
Aug 12, 2026
$0.10
-$0.33
+130.3%
$28.53M
Q1 2026
May 13, 2026
$0.57
-$0.39
+246.2%
$9.89M
Q4 2025
Mar 31, 2026
$3.14
$2.24
+40.2%
$0
OMER analyst price target
Median target $27.50 from 2 analysts, ranging $22.00 – $33.00.
Nama's AI scorecard currently rates Omeros Sell (4.0 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is OMER's P/E ratio?
Omeros trades at a trailing price-to-earnings ratio of 4.7.
When does OMER report earnings?
Omeros's next scheduled report is on Mar 31, 2027. Analysts expect EPS of $0.25.
What is the OMER price target?
The median analyst price target from 2 analysts is $27.50, with a range of $22.00 – $33.00.
Is OMER Shariah compliant?
Nama's AAOIFI-style screen reads Omeros as Can't Tell. A figure the screen needs is missing, so it can't tell.